[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
Aripiprazole |
Abilify |
Clinical Trial: Study of Aripiprazole in Patients with Acute Bipolar Mania
This study is currently recruiting patients.
|
Purpose
The purpose of this research study is to confirm the safety and effectiveness of aripiprazole therapy over 12 weeks in subjects with bipolar disorder experiencing symptoms of mania.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Bipolar Disorder | Drug: aripiprazole | Phase III |
MedlinePlus related topics: Bipolar Disorder
Study Type: Interventional
Study Design: Treatment, Safety/Efficacy Study
Official Title: A Phase III Study of Aripiprazole in Patients with Acute Bipolar Mania
Eligibility
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
Location and Contact Information
California
Local Institution, Pico Rivera, California, United States; Not yet recruiting
Local Institution, La Mesa, California, United States; Recruiting
Local Institution, Anaheim, California, United States; Recruiting
Local Institution, National City, California, United States; Recruiting
Local Institution, Cerritos, California, United States; Recruiting
Local Institution, San Diego, California, United States; Recruiting
District of Columbia
Local Institution, Washington, District of Columbia, United States; Recruiting
Florida
Local Institution, Maitland, Florida, United States; Recruiting
Local Institution, Tampa, Florida, United States; Not yet recruiting
Louisiana
Local Institution, Lake Charles, Louisiana, United States; Recruiting
New Mexico
Local Institution, Albuquerque, New Mexico, United States; Recruiting
Ohio
Local Institution, Cleveland, Ohio, United States; Not yet recruiting
Tennessee
Local Institution, Madison, Tennessee, United States; Recruiting
Texas
Local Institution, Desoto, Texas, United States; Recruiting
Wisconsin
Local Institution, Milwaukee, Wisconsin, United States; Not yet recruiting
Chile, Metropolitana
Local Institution, Santiago de Chile, Metropolitana, Chile; Recruiting
Croatia
Local Institution, Osijek, Croatia; Not yet recruiting
Local Institution, Zagreb, Croatia; Not yet recruiting
Local Institution, Rijeka, Croatia; Not yet recruiting
Local Institution, Zagreb, Croatia; Not yet recruiting
Local Institution, Zagreb, Croatia; Not yet recruiting
Mexico
Local Institution, Aguascalientes, Mexico; Not yet recruiting
Local Institution, San Luis Potosi, Mexico; Not yet recruiting
Local Institution, Distrito Federal, Mexico; Not yet recruiting
Local Institution, Distrito Federal, Mexico; Not yet recruiting
Local Institution, Nuevo Leon, Mexico; Not yet recruiting
Mexico, Distrito Federal
Local Institution, Mexico, Distrito Federal, Mexico; Not yet recruiting
Local Institution, Mexico, Distrito Federal, Mexico; Recruiting
Local Institution, Mexico, Distrito Federal, Mexico; Recruiting
Local Institution, Mexico, Distrito Federal, Mexico; Not yet recruiting
Mexico, Nuevo Leon
Local Institution, Monterrey, Nuevo Leon, Mexico; Recruiting
Local Institution, Monterrey, Nuevo Leon, Mexico; Recruiting
Russian Federation
Local Institution, Kazan, Russian Federation; Recruiting
Local Institution, Moscow, Russian Federation; Recruiting
Local Institution, Moscow, Russian Federation; Recruiting
Local Institution, Moscow, Russian Federation; Recruiting
Local Institution, Moscow, Russian Federation; Recruiting
Local Institution, Moscow, Russian Federation; Recruiting
Local Institution, Leningrad Region, Russian Federation; Recruiting
Local Institution, Nizhniy Novgorod, Russian Federation; Recruiting
Local Institution, St Petersburg, Russian Federation; Recruiting
Local Institution, St Petersburg, Russian Federation; Recruiting
Local Institution, St Petersburg, Russian Federation; Recruiting
Local Institution, Moscow, Russian Federation; Recruiting
Local Institution, Moscow, Russian Federation; Recruiting
Local Institution, St Petersburg, Russian Federation; Recruiting
Local Institution, Samara, Russian Federation; Not yet recruiting
South Africa, Gauteng
Local Institution, Pretoria, Gauteng, South Africa; Recruiting
Local Institution, Pretoria West, Gauteng, South Africa; Not yet recruiting
Local Institution, Garankua, Gauteng, South Africa; Not yet recruiting
South Africa, Kwa Zulu Natal
Local Institution, Durban, Kwa Zulu Natal, South Africa; Recruiting
South Africa, Kwa Zuluu Natal
Local Institution, Berea, Kwa Zuluu Natal, South Africa; Recruiting
More Information
Record last reviewed: March 2005
Last Updated: March 9, 2005
Record first received: November 19, 2004
ClinicalTrials.gov Identifier: NCT00097266
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- Abilify (Drug Digest)
- Abilify Consumer Information (U.S. Food and Drug Administration)

Not Signed In -


